HPLC Analysis of Cortocisteroids in Urine on Discovery® HS F5 after SPE using Discovery® DSC-CN
材料
分析色谱柱
产品编号
说明
价格
CONDITIONS
sample preparation
SPE (Solid Phase Extraction)
sample/matrix
human urine spiked with corticosteroids at 0.5 and 1.0 μg/mL and diluted in DI water (1:1, v/v)
SPE well plate
Discovery DSC-CN 96-well SPE, 100 mg/well (575636-U)
condition
1 mL methanol; 1 mL DI water.
sample addition
1 mL spiked urine
washing
1 mL 20% methanol
elution
1 mL methanol
eluate post-treatment
Evaporate eluate with nitrogen at 30 °C. Reconstitute in 200 μL mobile phase.
column
Discovery HS F5, 5 cm x 4.6 mm I.D., 3 μm particles (567504-U)
mobile phase
[A] methanol; [B] DI water; (40:60, A:B)
flow rate
1.5 mL/min
column temp.
35 °C
detector
UV, 240 nm
injection
5 μL
说明
法律信息
Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany